The gene source chain system will create the world's first distributed storage network public chain system that provides genetic data and individual health data. Health and medical providers, including chronic disease management agencies and health counseling providers, can use the Gene Source Chain System to create DApps. These applications will provide users with personalized and accurate health services based on genome and health data, subject to user consent. As a proof of concept, the Gene Source Chain Foundation will also support the creation of a gamified health DApp to help build the ecosystem.
Amoveo (VEO) is a highly scalable proof-of-work blockchain driven by its community and aimed for prediction markets, investment and insurance contracts, and various derivatives, such as stable coins. Amoveo is a blockchain meant for enforcement of investment and insurance contracts. Amoveo contracts are enforced using state-channels. This means fees are low, contracts are nearly instant and can support a global audience. Amoveo has oracle technology. Amoveo can learn facts about our world and enforce the outcome of contracts that are governed by these facts. This, for example, enables you to bet on the price of Amazon shares. The variables that define how to participate in Amoveo can be modified by the Amoveo community using a built-in process. This way Amoveo will always stay optimally tuned to produce the best results.